Genetic common variants that impair PON1 expression or enzymatic efficiency have been linked to increased oxidative burden, endothelial dysfunction, and a greater susceptibility to age-related conditions such as cardiovascular disease and metabolic syndrome [51,52]. This evidence concerns the gene PON1 and cardiovascular disorder.